https://www.europeanpharmaceuticalreview.com/news/183546/chikungunya-vaccine-demonstrates-99-percent-immune-response/
0
0
6/13/23 at 2:15pm
Organization
European Pharmaceutical Review
Authors
If approved, VLA1553 could become the first licensed chikungunya vaccine available to address this unmet medical need.
Create an account
or login to join the discussion